Wow, hopper is such a liability. The fact that it’s an all retail offer makes me think he’s lost credibility over the past 1 to 2 years in the investor circles. If you were approached by hopper to invest millions into his biotechs you’d run a mile based on his inability to provide any medium term returns and only huge losses for the past years. As slick said, he’s on the nose. Imo also.
Ann: Entitlement Offer to raise approximately $10 million, page-47
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
